Research Compliance
Considerations for Transitioning from Paper to eSource
Explore the benefits of switching from paper to eSource, tips for implementation, and how to maintain compliance.
Q&A: FDA Updates: BIMO – What Sponsors Need to Know
Advarra experts Joan Versaggi and Leslie Paul answer questions from the webinar- FDA Updates: BIMO – What Sponsors Need to Know.
Unique Ethical Issues in Phase I Oncology Studies
An essential step in research, Phase I oncology studies raise unique ethical challenges for sponsors, investigators, and IRBs.
Implementing Site-Centric Technology to Effectively Manage Your Clinical Trials
This webinar provides an overview of the benefits of adopting new clinical research technologies (focusing primarily on a CTMS).
The ROI of Site-Centric Training and Support
Download our white paper to learn how to maximize your research investment for site-centric training and support.
Integrating Expert Opinions: Why Your Clinical Trial Needs an EAC
In this webinar, we discuss the role of independent endpoint adjudication committees, from charter creation through end of study closeout.
Does This Study Require IBC Review?
While clinical research professionals are familiar with the role of the IRB to protect research subjects, most are unfamiliar with the added need for an Institutional Biosafety Committee (IBC).
Decentralized Recruiting, Enrollment, and Participant Engagement with a CTMS
Watch our webinar highlighting a CTMS' capabilities to streamline research, facilitate compliance, and enhance the participant experience.
FDA Update: BIMO – What Sponsors Need to Know
This webinar highlights key changes to the compliance program and provides recommended best practices for inspection readiness programs.
Advarra Trend Report: The Future of Work in Clinical Research
Download our report to learn more how the COVID-19 pandemic impacted the future of the clinical research workforce.
When do I Need a DMC?
View our infographic to learn the basics of a data monitoring committee (DMC), also referred to as data safety monitoring board (DSMB).
The Importance of Keeping DSMBs Independent
By ensuring the DSMB is truly independent from study conduct, sponsors make trial data more trustworthy and enhance public confidence.
Subscribe to our monthly email
Receive updates monthly about webinars for CEUs, white papers, podcasts, and more.
Advancing Clinical Research: Safer, Smarter, Faster™
Copyright © 2024 Advarra. All Rights Reserved.